Sector Charles River Laboratories International, Inc. Deutsche Boerse AG
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 196.10 EUR | -1.78% |
|
+1.76% | +14.11% |
| 07-20 | Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… |  |
| 07-13 | BofA Adjusts Price Target on Charles River Laboratories International to $264 From $220 | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.14% | -0.67% | +4.79% | +16.06% | +4.17% | -0.88% | +11.02% | -18.29% | +206.96% | 47.74B | |
| -2.24% | +0.31% | +0.98% | +26.95% | +130.83% | +393.45% | +615.13% | +521.15% | - | 39.98B | |
| +1.40% | +3.69% | +18.07% | +10.83% | +8.77% | +12.21% | +46.79% | +5.68% | +1,106.06% | 36.23B | |
| +13.94% | +20.49% | +27.10% | +52.81% | +7.78% | +22.85% | +7.42% | -0.99% | +211.78% | 35.59B | |
| -0.73% | +3.38% | +6.93% | -10.01% | +2.91% | +4.94% | +41.45% | -17.49% | +145.10% | 27.91B | |
| +0.40% | -0.30% | -2.42% | +14.57% | - | - | - | - | - | 16.71B | |
| -3.12% | +7.39% | +8.33% | +39.38% | +1.66% | +26.03% | +124.08% | +226.85% | - | 16.45B | |
| +2.39% | -1.64% | -0.64% | +14.66% | +9.81% | +4.74% | +9.95% | -31.52% | +105.21% | 13.21B | |
| +6.79% | +8.17% | +6.11% | +75.86% | -1.09% | -4.97% | -28.52% | -21.73% | +129.05% | 12.93B | |
| +0.63% | +0.61% | +1.51% | +34.69% | +22.55% | +23.09% | -13.99% | -39.53% | +160.23% | 11.16B | |
| -3.89% | -7.40% | +28.76% | +13.87% | -9.63% | +90.88% | +519.59% | +250.40% | +2,496.66% | 11.1B | |
| -0.08% | -0.02% | +1.22% | +57.16% | +77.76% | +238.30% | +546.60% | - | - | 10.08B | |
| -2.71% | -4.17% | +43.31% | +21.99% | +32.68% | +22.31% | +43.80% | -58.72% | - | 9.54B | |
| -1.18% | +3.58% | -31.88% | -22.96% | -30.10% | +34.32% | +38.98% | +46.57% | +91.75% | 9.25B | |
| -3.53% | -6.36% | -1.81% | +26.61% | +36.43% | +140.18% | +386.08% | +78.21% | - | 9.05B | |
| -6.33% | -6.94% | -9.76% | -8.11% | +0.36% | +431.55% | +1,912.31% | +24.74% | - | 8.8B | |
| -4.23% | -4.45% | -8.32% | +47.92% | +80.49% | +93.12% | +75.59% | +95.96% | +4.92% | 8.79B | |
| +0.94% | -1.06% | +12.27% | +35.20% | +56.68% | +143.23% | +616.82% | +191.21% | - | 8.72B | |
| +2.92% | +4.32% | +7.28% | +24.28% | -10.68% | -21.21% | -19.61% | -26.62% | +55.68% | 8.5B | |
| Average | +0.08% | +0.86% | +5.89% | +24.83% | +23.41% | +91.90% | +274.08% | +72.11% | +428.49% | 17.99B | |
| Weighted average by Cap. | +1.03% | +1.51% | +7.92% | +23.76% | +26.63% | +88.18% | +209.66% | +89.22% | +429.24% |
- Stock Market
- Stocks
- CRL Stock
- RV6 Stock
- Sector Charles River Laboratories International, Inc.
Select your edition
All financial news and data tailored to specific country editions
